get a key
steadybase-$ company TSHA
account_id none on file
legal_name Taysha Gene Therapies, Inc.
ticker TSHA
cik 1806310
domain tayshagtx.com
entry_point_account_id none on file
name Taysha Gene Therapies Inc.
exchange Nasdaq
sector Health Care
calls 0 filings 0 executives 5 family 0
why_nownone on file
callsnone on file
filingsnone on file
executives
Alison Long director - receipt
Kathleen Reape director - receipt
Sean Nolan Chief Executive Officer - receipt
Sean Stalfort September 4, 2020/in Board of Directors - receipt
Sukumar Nagendran President - receipt
familynone on file
upcoming
2026-11-03 earnings call scheduled ir
changes
2023-11-01 director, appointed sec_8k
2023-06-22 director, appointed sec_8k
2022-12-22 Chief Executive Officer, appointed sec_8k
2022-12-22 President, appointed sec_8k
2020-11-24 director, appointed sec_8k
mcp_package_hint
steadybase-$